Differentiation-inducing quinolines as experimental breast cancer agents in the MCF-7 human breast cancer cell model.
Martirosyan
Anna R
AR
Department of Biochemistry & Molecular Pharmacology, West Virginia University, Morgantown, WV 26506, USA.
Rahim-Bata
Rayhana
R
Freeman
Andrew B
AB
Clarke
Charles D
CD
Howard
Rachael L
RL
Strobl
Jeannine S
JS
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000473:pathology; D018797:Cell Cycle Proteins / Q000378:metabolism; D016923:Cell Death / Q000187:drug effects / Q000502:physiology; D002454:Cell Differentiation / Q000187:drug effects* / Q000502:physiology; D049109:Cell Proliferation / Q000187:drug effects; D004268:DNA-Binding Proteins / Q000378:metabolism; D050684:E2F Transcription Factors; D050687:E2F1 Transcription Factor; D006367:HeLa Cells; D006655:Histone Deacetylases / Q000378:metabolism; D006801:Humans; D011804:Quinolines / Q000494:pharmacology*; D014157:Transcription Factors / Q000378:metabolism; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D050684:E2F Transcription Factors; D050687:E2F1 Transcription Factor; C493753:E2F1 protein, human; D011804:Quinolines; D014157:Transcription Factors; C037219:quinoline; D006655:Histone Deacetylases